Mortality As a Measure of Treatment Effect in Clinical Trials Recruiting Critically Ill Patients*

被引:10
作者
Friedrich, Jan O. [1 ,2 ]
Harhay, Michael O. [3 ]
Angus, Derek C. [4 ]
Burns, Karen E. A. [1 ,2 ]
Cook, Deborah J. [5 ]
Fergusson, Dean A. [6 ]
Finfer, Simon [7 ]
Hebert, Paul [8 ]
Rowan, Kathy [9 ]
Rubenfeld, Gordon [1 ,2 ,10 ]
Marshall, John C. [1 ,11 ]
机构
[1] Univ Toronto, St Michaels Hosp, Dept Crit Care Med, Toronto, ON, Canada
[2] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON, Canada
[3] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA
[4] Univ Pittsburgh, CRISMA Ctr, Med Ctr, Pittsburgh, PA USA
[5] McMaster Univ, Hamilton, ON, Canada
[6] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[7] George Inst, Sydney, NSW, Australia
[8] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada
[9] Intens Care Natl Audit & Resource Ctr ICNARC, London, England
[10] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[11] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON, Canada
基金
美国国家卫生研究院;
关键词
ARDS; critical care; mortality; sepsis; trials; RESPIRATORY-DISTRESS-SYNDROME; INTENSIVE-CARE; SEVERE SEPSIS; SEPTIC SHOCK; EFFICACY; SAFETY; MULTICENTER; OUTCOMES; HYDROCORTISONE; VENTILATION;
D O I
10.1097/CCM.0000000000005721
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
OBJECTIVES:All-cause mortality is a common measure of treatment effect in ICU-based randomized clinical trials (RCTs). We sought to understand the performance characteristics of a mortality endpoint by evaluating its temporal course, responsiveness to differential treatment effects, and impact when used as an outcome measure in trials of acute illness. DATA SOURCES:We searched OVID Medline for RCTs published from 1990 to 2018. STUDY SELECTION:We reviewed RCTs that had randomized greater than or equal to 100 patients, were published in one of five high-impact general medical or eight critical care journals, and reported mortality at two or more distinct time points. We excluded trials recruiting pediatric or neonatal patients and cluster RCTs. DATA EXTRACTION:Mortality by randomization group was recorded from the article or estimated from survival curves. Trial impact was assessed by inclusion of results in clinical practice guidelines. DATA SYNTHESIS:From 2,592 potentially eligible trials, we included 343 RCTs (228,784 adult patients). While one third of all deaths by 180 days had occurred by day 7, the risk difference between study arms continued to increase until day 60 (p = 0.01) and possibly day 90 (p = 0.07) and remained stable thereafter. The number of deaths at ICU discharge approximated those at 28-30 days (95% [interquartile range [IQR], 86-106%]), and deaths at hospital discharge approximated those at 60 days (99% [IQR, 94-104%]). Only 13 of 43 interventions (30.2%) showing a mortality benefit have been adopted into widespread clinical practice. CONCLUSIONS:Our findings provide a conceptual framework for choosing a time horizon and interpreting mortality outcome in trials of acute illness. Differential mortality effects persist for 60 to 90 days following recruitment. Location-based measures approximate time-based measures for trials conducted outside the United States. The documentation of a mortality reduction has had a modest impact on practice.
引用
收藏
页码:222 / 230
页数:9
相关论文
共 41 条
[21]   Variation in Long-Term Acute Care Hospital Use After Intensive Care [J].
Kahn, Jeremy M. ;
Werner, Rachel M. ;
Carson, Shannon S. ;
Iwashyna, Theodore J. .
MEDICAL CARE RESEARCH AND REVIEW, 2012, 69 (03) :339-350
[22]   KDIGO Clinical Practice Guidelines for Acute Kidney Injury [J].
Khwaja, Arif .
NEPHRON CLINICAL PRACTICE, 2012, 120 (04) :C179-C184
[23]   Global Collaboration in Acute Care Clinical Research: Opportunities, Challenges, and Needs [J].
Marshall, John C. .
CRITICAL CARE MEDICINE, 2017, 45 (02) :311-320
[24]   Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock A Randomized Clinical Trial [J].
Morelli, Andrea ;
Ertmer, Christian ;
Westphal, Martin ;
Rehberg, Sebastian ;
Kampmeier, Tim ;
Ligges, Sandra ;
Orecchioni, Alessandra ;
D'Egidio, Annalia ;
D'Ippoliti, Fiorella ;
Raffone, Cristina ;
Venditti, Mario ;
Guarracino, Fabio ;
Girardis, Massimo ;
Tritapepe, Luigi ;
Pietropaoli, Paolo ;
Mebazaa, Alexander ;
Singer, Mervyn .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (16) :1683-1691
[25]   Causes and Characteristics of Death in Intensive Care Units A Prospective Multicenter Study [J].
Orban, Jean-Christophe ;
Walrave, Yannick ;
Mongardon, Nicolas ;
Allaouchiche, Bernard ;
Argaud, Laurent ;
Aubrun, Frederic ;
Barjon, Genevieve ;
Constantin, Jean-Michel ;
Dhonneur, Gilles ;
Durand-Gasselin, Jacques ;
Dupont, Herve ;
Genestal, Michele ;
Goguey, Chloe ;
Goutorbe, Philippe ;
Guidet, Bertrand ;
Hyvernat, Herve ;
Jaber, Samir ;
Lefrant, Jean-Yves ;
Malledant, Yannick ;
Morel, Jerome ;
Ouattara, Alexandre ;
Pichon, Nicolas ;
Robardey, Anne-Marie Guerin ;
Sirodot, Michel ;
Theissen, Alexandre ;
Wiramus, Sandrine ;
Zieleskiewicz, Laurent ;
Leone, Marc ;
Ichai, Carole .
ANESTHESIOLOGY, 2017, 126 (05) :882-889
[26]   Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab1)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels [J].
Panacek, EA ;
Marshall, JC ;
Albertson, TE ;
Johnson, DH ;
Johnson, S ;
MacArthur, RD ;
Miller, M ;
Barchuk, WT ;
Fischkoff, S ;
Kaul, M ;
Teoh, L ;
Van Meter, L ;
Daum, L ;
Lemeshow, S ;
Hicklin, G ;
Doig, C .
CRITICAL CARE MEDICINE, 2004, 32 (11) :2173-2182
[27]   Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome. [J].
Papazian, Laurent ;
Forel, Jean-Marie ;
Gacouin, Arnaud ;
Penot-Ragon, Christine ;
Perrin, Gilles ;
Loundou, Anderson ;
Jaber, Samir ;
Arnal, Jean-Michel ;
Perez, Didier ;
Seghboyan, Jean-Marie ;
Constantin, Jean-Michel ;
Courant, Pierre ;
Lefrant, Jean-Yves ;
Guerin, Claude ;
Prat, Gwenael ;
Morange, Sophie ;
Roch, Antoine .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (12) :1107-1116
[28]   SHOULD MORBIDITY REPLACE MORTALITY AS AN END-POINT FOR CLINICAL-TRIALS IN INTENSIVE-CARE [J].
PETROS, AJ ;
MARSHALL, JC ;
VANSAENE, HKF .
LANCET, 1995, 345 (8946) :369-371
[29]   Drotrecogin Alfa (Activated) in Adults with Septic Shock [J].
Ranieri, V. Marco ;
Thompson, B. Taylor ;
Barie, Philip S. ;
Dhainaut, Jean-Francois ;
Douglas, Ivor S. ;
Finfer, Simon ;
Gardlund, Bengt ;
Marshall, John C. ;
Rhodes, Andrew ;
Artigas, Antonio ;
Payen, Didier ;
Tenhunen, Jyrki ;
Al-Khalidi, Hussein R. ;
Thompson, Vivian ;
Janes, Jonathan ;
Macias, William L. ;
Vangerow, Burkhard ;
Williams, Mark D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (22) :2055-2064
[30]   Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure [J].
Rochwerg, Bram ;
Brochard, Laurent ;
Elliott, Mark W. ;
Hess, Dean ;
Hill, Nicholas S. ;
Nava, Stefano ;
Navalesi, Paolo ;
Antonelli, Massimo ;
Brozek, Jan ;
Conti, Giorgio ;
Ferrer, Miquel ;
Guntupalli, Kalpalatha ;
Jaber, Samir ;
Keenan, Sean ;
Mancebo, Jordi ;
Mehta, Sangeeta ;
Raoof, Suhail .
EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)